About Longevity Vision Fund
Longevity Vision Fund is a venture capital firm founded in 2018. It is primarily based out of New York City, United States. As of Aug 2022, Longevity Vision Fund has invested in 17 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $300M Series C round of Tessera Therapeutics along with Flagship Pioneering. This round also saw participation from T. Rowe Price and other investors.
Overall, Longevity Vision Fund portfolio has seen 2 unicorns, 1 IPO and 2 acquisitions including key companies like 4D Molecular Therapeutics, Freenome and Insilico. A lot of funds co-invest with Longevity Vision Fund, with names like Bold Capital Partners sharing a substantial percentage of its portfolio.
Longevity Vision Fund has team of 10 people including 3 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Longevity Vision Fund's Year-on-Year Investment Trends
Longevity Vision Fund has invested in 17 companies over the last 6 years, with an average of 1 new investment annually in the last 5 years. Its most recent first time investment was in Tessera Therapeutics and most recent follow-on round was in Senda Biosciences.
Year | No. of Investments | ||
---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 1 | 1 | 2 |
2021 | 2 | 0 | 2 |
2020 | 3 | 1 | 4 |
2019 | 3 | 0 | 3 |

Get Longevity Vision Fund's portfolio delivered to your inbox!
Longevity Vision Fund's Investments by Stage
Longevity Vision Fund has made 5 investments in Series B stage with an average round size of $70.1M, 2 investments in Series A stage with an average round size of $4M and 2 investments in Series C stage with an average round size of $188M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
---|---|
Series B | 5 |
Series A | 2 |
Series C | 2 |
Longevity Vision Fund's Investments by Sector
Longevity Vision Fund has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Artificial Intelligence - Industry Applications and Enterprise Applications. Notably, it has invested in 12 Enterprise (B2B) companies, 12 Tech companies, 6 Artificial intelligence companies and at least 5 companies focusing on Software.
Note: We have considered here, only first round of investments
Sector | No. of Investments |
---|---|
Life Sciences | 7 |
High Tech | 5 |
HealthTech | 4 |
Artificial Intelligence - Industry Applications | 3 |
Enterprise Applications | 3 |
Others | 2 |
Longevity Vision Fund's Investments by Geography
Longevity Vision Fund has made most investments in United States (8), followed by China where it has made 1 investment.
Note: We have considered here, only first round of investments
Country | No. of Investments |
---|---|
United States | 8 |
China | 1 |
Longevity Vision Fund's recent investments
Here are the most recent investments by Longevity Vision Fund:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
---|---|---|---|---|---|
Aug 16, 2022 | United States | Series C | $123M | [+5] | |
Apr 19, 2022 | United States | Series C | $300M | ADIA [+8] | |
Nov 02, 2021 | United States | Series B | $100M | ||
Jun 10, 2021 | United States | Series B | $98M | TMCP [+3] | |
Aug 20, 2020 | United States | Series B | $40M | TDK Ventures [+10] |
Unicorns in Longevity Vision Fund's Portfolio
Here is a list of unicorns in Longevity Vision Fund's portfolio:
ÃØÃÜÑо¿Ëù Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
---|---|---|---|---|---|---|---|
64 | AI-enabled bioinformatics platform for drug discovery and biomarker development | 2014 | Hong Kong | Series E | uvvdfdy | ||
72 | Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | San Francisco | Series E | ruktrqp |
IPOs and Publicly Listed companies in Longevity Vision Fund's Portfolio
Here are Longevity Vision Fund's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
---|---|---|---|---|
Dec 11, 2020 | Jun 16, 2020 | Series C | $75M |
Acquired companies in Longevity Vision Fund's Portfolio
Here are Longevity Vision Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
---|---|---|---|---|
Jun 30, 2023 | Mar 17, 2020 | Series B | $80.3M | |
Sep 02, 2020 | Jul 14, 2020 | Series A | Undisclosed |
Team profile of Longevity Vision Fund
Longevity Vision Fund has a team of 10 membersÌýincluding 3 PartnersÌýlocated in United States, United Kingdom and . Longevity Vision Fund's team does not sit on the board of any company as of now.Here is a list of all team members in Longevity Vision Fund:
Name | Designation | Location | Board Memberships | Contact details |
---|---|---|---|---|
Partner | London | - | ||
Partner | London | - | ||
Partner | New York City | - | ||
Advisor | United States | - | ||
Advisor | Copenhagen | - | - | |
Advisor | Birmingham | - | - | |
Associate | Zurich | - | ||
Analyst | Boston | - | ||
Analyst | New York | - |
Co-investors of Longevity Vision Fund
Over the past 6 years, 122 investors have co-invested in Longevity Vision Fund's portfolio companies.
- Invested before Longevity Vision Fund:ÌýJuvenescence, Pfizer Venture Investments and 35 others have invested in rounds before Longevity Vision Fund. There are 2 companies where Juvenescence has invested before Longevity Vision Fund and 1 company where Pfizer Venture Investments has invested before Longevity Vision Fund.
- Top Co-investors of Longevity Vision Fund:Ìý53 investors entered a company along with Longevity Vision Fund. These include investors like Bold Capital Partners (2 companies).
- Invested after Longevity Vision Fund:ÌýA total of 32 investors have invested in Longevity Vision Fund's portfolio after their investments. Top Investors include TDK Ventures (1 company), Solasta Ventures (1 company) and Action Potential Venture Capital (1 company).

Get full list of Longevity Vision Fund's co-investors delivered to your inbox!
Recent News related to Longevity Vision Fund
•
BioPharmaDive•Aug 16, 2022•Senda Biosciences, Flagship Pioneering, Qatar Investment Authority, and 4 others
•
PEdaily•Apr 28, 2022•Tessera Therapeutics, ADIA, Alaska Permanent Fund, Altitude Life Science Ventures and 7 others
•
Global Legal Chronicle•Apr 22, 2022•Tessera Therapeutics, ADIA, Alaska Permanent Fund, Altitude Life Science Ventures and 17 others
•
•
•
FinSMEs•Jun 12, 2021•Senda Biosciences, Magnum Partners, Longevity Vision Fund, TMCP and 5 others
•
Medical Product Outsourcing•Oct 08, 2020•Exo, Remagine Ventures, Action Potential Venture Capital, TDK Ventures and 10 others
•
ACN Newswire•Sep 02, 2020•Deep Longevity, Human Longevity, Emerging Technology Partners, Bold Capital Partners and 1 other
•
MassDevice•Aug 24, 2020•Remagine Ventures, Exo, Action Potential Venture Capital, Intel Capital and 10 others
•
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies
212K+ Investors
580K+ Funding Rounds
207K+ Acquisitions
2.9K+ Sectors
57K+ Business Models







